CompletedNot Applicable

Clinical Outcomes and Prognostic Factors of Robotic Assisted Rectal Cancer Resection Alone vs. Robotic Rectal Cancer Resection With Natural Orifice Specimen Extraction

98 participantsStarted 2015-01-06

Plain-language summary

Robotic rectal cancer resection with natural orifice extraction is a recently developed minimally invasive surgery for patients with rectal cancer. However, it's safety and feasibility remain undiscussed and controversial. This study reported the clinical outcomes and prognostic factors of robotic assisted rectal cancer resection alone vs. robotic rectal cancer resection with natural orifice extraction to discuss aforementioned question.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. T stage 1-3;
✓. aged between 18 to 75;
✓. the tumor margin is at least 4 cm from the anus;
✓. body mass index ≤30kg/m2;
✓. no distant metastases； (6）tumor size≤5cm.

Exclusion criteria

✕. emergency surgery for intestinal obstruction or massive bleeding;
✕. history of abdominal or pelvic surgery.

What they're measuring

Overall survival

Timeframe: Up to 36 months

Disease-free survival

Timeframe: Up to 36 months

Trial details

NCT IDNCT04265417

SponsorTaiyuan Li

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-12-01

View on ClinicalTrials.gov More Rectal Neoplasms trials